LSP1 and acute myeloid leukemia: Interestingly, LSP1 and CRIP1 were also expressed highly in immune cell subsets, including CD8+ T cells, exhausted CD8+ T cells, and mono/macrophages (Figures 6B–F), suggesting that targeting LSP1 and CRIP1 for AML might present a promising strategy.